Kristine Kleivi Sahlberg

1 ta ish

Oslo University Hospital

1. MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

   Lisa Svartdal Normann, Miriam R. R. Aure, Suvi‐Katri Leivonen +5

   Maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.512524